Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

105.57
Delayed Data
As of 4:02pm ET
 -2.93 / -2.70%
Today’s Change
92.28
Today|||52-Week Range
124.52
+0.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues759.3M862.9M950.8M879.4M
 
 
 
 
 
Cost of Goods Sold162.7M170.6M154.9M193.0M
 
 
 
 
 
Depreciation And Amortization16.6M15.8M14.8M14.8M
 
 
 
 
 
 
Operating ExpensesGross Income580.0M676.6M781.0M671.5M
 
 
 
 
 
General Expenses147.2M153.2M163.5M156.3M
 
 
 
 
 
Research And Development55.4M65.5M71.2M70.6M
 
 
 
 
 
Total Operating Expenses326.4M339.5M333.3M364.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income432.8M523.4M617.5M515.2M
 
 
 
 
 
Extraordinary Credit0.004.2M0.000.00
 
 
Extraordinary Charge-2.6M---3.0M-276.0K
 
 
 
 
Interest Expense On Debt1.5M928.0K473.0K0.00
 
 
 
 
Other Expenses8.5M44.4M9.7M31.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income443.9M581.7M636.8M560.8M
 
 
 
 
 
Income Taxes-82.7M-96.1M-95.3M-103.8M
 
 
 
 
 
Minority Interest-472.0K-577.0K-339.0K-310.0K
 
 
 
 
 
Discontinued Operations-319.0K-787.0K-236.0K-352.0K
 
 
 
 
 
Net Income360.4M484.3M540.9M456.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.3M42.8M42.8M41.3M
 
 
 
 
 
Shares To Calculate EPS Diluted44.3M42.8M42.8M41.3M
 
 
 
 
 
 
Earnings Per ShareEPS$8.14$11.31$12.62$11.05
 
 
 
 
 
EPS Diluted$8.14$11.31$12.63$11.05